JP2010524984A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524984A5
JP2010524984A5 JP2010504490A JP2010504490A JP2010524984A5 JP 2010524984 A5 JP2010524984 A5 JP 2010524984A5 JP 2010504490 A JP2010504490 A JP 2010504490A JP 2010504490 A JP2010504490 A JP 2010504490A JP 2010524984 A5 JP2010524984 A5 JP 2010524984A5
Authority
JP
Japan
Prior art keywords
oxo
carbonyl
ethoxy
piperazine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010504490A
Other languages
English (en)
Japanese (ja)
Other versions
JP5309131B2 (ja
JP2010524984A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/002790 external-priority patent/WO2008128647A1/en
Publication of JP2010524984A publication Critical patent/JP2010524984A/ja
Publication of JP2010524984A5 publication Critical patent/JP2010524984A5/ja
Application granted granted Critical
Publication of JP5309131B2 publication Critical patent/JP5309131B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010504490A 2007-04-23 2008-04-09 P2y12アンタゴニストとしてのキノリン−カルボキサミド誘導体 Expired - Fee Related JP5309131B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07008209.4 2007-04-23
EP07008209 2007-04-23
PCT/EP2008/002790 WO2008128647A1 (en) 2007-04-23 2008-04-09 Quinoline-carboxamide derivatives as p2y12 antagonists

Publications (3)

Publication Number Publication Date
JP2010524984A JP2010524984A (ja) 2010-07-22
JP2010524984A5 true JP2010524984A5 (enExample) 2011-05-12
JP5309131B2 JP5309131B2 (ja) 2013-10-09

Family

ID=38462433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504490A Expired - Fee Related JP5309131B2 (ja) 2007-04-23 2008-04-09 P2y12アンタゴニストとしてのキノリン−カルボキサミド誘導体

Country Status (18)

Country Link
US (1) US8669266B2 (enExample)
EP (1) EP2148871A1 (enExample)
JP (1) JP5309131B2 (enExample)
KR (1) KR20100015886A (enExample)
CN (1) CN101663293B (enExample)
AR (1) AR066225A1 (enExample)
AU (1) AU2008241091B2 (enExample)
BR (1) BRPI0810462A2 (enExample)
CA (1) CA2684644A1 (enExample)
CL (1) CL2008001157A1 (enExample)
IL (1) IL201620A (enExample)
MX (1) MX2009011089A (enExample)
MY (1) MY153427A (enExample)
PA (1) PA8777901A1 (enExample)
PE (1) PE20090241A1 (enExample)
TW (1) TW200848042A (enExample)
UY (1) UY31039A1 (enExample)
WO (1) WO2008128647A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE281849T1 (de) 2001-02-28 2004-11-15 Uroteq Inc Verfahren zur herstellung antimikrobieller polymeroberflächen
WO2009082526A2 (en) * 2007-10-05 2009-07-02 Pharmacopeia, Inc. Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
AR069494A1 (es) 2007-11-29 2010-01-27 Actelion Pharmaceuticals Ltd Derivados de acidos fosfonicos
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
RU2401831C2 (ru) * 2008-12-15 2010-10-20 Алла Хем, Ллс Средство, снижающее влечение к алкоголю, фармацевтическая композиция и способы ее получения, лекарственное средство и способ лечения
AU2010233378A1 (en) * 2009-04-08 2011-11-24 Actelion Pharmaceuticals Ltd. 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as ADP receptor antagonists
BRPI1015145A2 (pt) 2009-04-22 2018-01-30 Actelion Pharmaceuticals Ltd derivados de tiazol e seu uso como receptores antagonistas de p2y12
JP5597202B2 (ja) 2009-08-28 2014-10-01 第一三共株式会社 3−(ビアリールオキシ)プロピオン酸誘導体
AR079451A1 (es) * 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
ES2609578T3 (es) 2011-03-04 2017-04-21 Glaxosmithkline Intellectual Property Development Limited Amino-quinolinas como inhibidores de quinasa
TWI547494B (zh) 2011-08-18 2016-09-01 葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之胺基喹唑啉類
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
CN102584852B (zh) * 2011-12-30 2014-08-13 厦门大学 真菌代谢产物桥南霉素及其制备方法和应用
AR092529A1 (es) 2012-09-13 2015-04-22 Glaxosmithkline Llc Compuesto de aminoquinazolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
AR092530A1 (es) 2012-09-13 2015-04-22 Glaxosmithkline Llc Compuesto de amino-quinolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
EP2725025A1 (fr) * 2012-10-26 2014-04-30 Sanofi Dérives de 1H-indole-3-carboxamide et leurs utilisation comme antagonistes du P2Y12
TWI630203B (zh) 2013-02-21 2018-07-21 葛蘭素史克智慧財產發展有限公司 做為激酶抑制劑的喹唑啉類
CN104109158A (zh) * 2013-04-16 2014-10-22 上海医药工业研究院 一种纯化利伐沙班的方法
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
DE102015217396B4 (de) 2014-09-11 2018-07-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. System, insbesondere System zur Eingabesteuerung für eine Arbeitshilfe
CN106496249B (zh) * 2015-09-07 2019-12-13 江苏恒瑞医药股份有限公司 噁唑并吲哚类衍生物、其制备方法及其在医药上的应用
US10730868B2 (en) * 2016-07-14 2020-08-04 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
UA124073C2 (uk) 2016-09-22 2021-07-14 Ідорсія Фармасьютікалз Лтд Кристалічні форми гідрохлориду складного бутилового ефіру 4-((r)-2-{[6-((s)-3-метоксипіролідин-1-іл)-2-фенілпіримідин-4-карбоніл]-аміно}-3-фосфонопропіоніл)-піперазин-1-карбонової кислоти
MY205605A (en) 2017-03-15 2024-10-29 Idorsia Pharmaceuticals Ltd Subcutaneous administration of a p2y12 receptor antagonist
CN107648607A (zh) * 2017-09-11 2018-02-02 南昌大学 嘌呤2y12受体拮抗剂在制备糖尿病神经病理损伤疾病药物中的应用
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
WO2023108363A1 (en) * 2021-12-13 2023-06-22 Beijing Honghui Meditech Co., Ltd Pyrimidine-annulated triazole derivatives and their use in platelet aggregation inhibition
CN115429874A (zh) * 2022-09-20 2022-12-06 暨南大学 水蛭素靶向并抑制dpp4治疗糖尿病

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
ZA985247B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
TR200100149T2 (tr) 1998-07-06 2001-10-22 Bristol-Myers Squibb Company Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
AU5546000A (en) 1999-06-14 2001-01-02 Protherics Molecular Design Limited Compounds
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6861424B2 (en) * 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
BRPI0212726B8 (pt) 2001-09-21 2021-05-25 Bristol Myers Squibb Co compostos contendo lactamas, e derivados dos mesmos, composição farmacêutica que os compreende e seus usos
CN1747732A (zh) * 2002-12-11 2006-03-15 舍林股份公司 作为血小板腺苷二磷酸受体拮抗剂的2-氨基羰基喹啉化合物
MXPA06000675A (es) 2003-07-24 2006-04-19 Astellas Pharma Inc Derivado de quinolona o sal del mismo.
US7157445B2 (en) * 2004-02-26 2007-01-02 Aventis Pharma S.A. Administration of enoxaparin sodium to patients with severe renal impairment
JP2008094720A (ja) 2005-01-20 2008-04-24 Astellas Pharma Inc キノロン誘導体のプロドラッグ又はその塩
TW200640877A (en) * 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
EP1931657B1 (en) * 2005-08-17 2013-12-25 Merck Sharp & Dohme Corp. Novel high affinity quinoline-based kinase ligands

Similar Documents

Publication Publication Date Title
JP2010524984A5 (enExample)
CN115551867B (zh) 稠合三环类化合物、其药物组合物及用途
CA2566108C (en) Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
JP5309131B2 (ja) P2y12アンタゴニストとしてのキノリン−カルボキサミド誘導体
CN108473498B (zh) 作为IRAK4调节剂的吡唑并[1,5a]嘧啶衍生物
CA2787291C (en) 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
CN119677749A (zh) 氮杂喹唑啉泛KRas抑制剂
KR20220004100A (ko) 안드로겐 수용체를 표적 분해하는 이중 기능성의 키메라 헤테로 고리 화합물 및 이의 용도
KR20220022114A (ko) 헌팅턴병 치료 화합물
JP2007537231A5 (enExample)
JP2015522002A5 (enExample)
SG183218A1 (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
JP7254078B2 (ja) Pde1阻害剤としての置換フラノピリミジン化合物
EP2491038A1 (en) Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
CN106715419A (zh) 用作tank‑结合激酶抑制剂化合物的氨基三嗪衍生物
HRP20210935T1 (hr) Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak
KR20100066492A (ko) C형 간염 치료용 화합물
AU2019286312B2 (en) New isoxazolyl ether derivatives as GABA A alpha5 PAM
KR20230107291A (ko) PPARγ 조절제 및 사용 방법
CN1968949B (zh) 脯氨酸衍生物和其作为二肽基肽酶iv抑制剂的用途
DK2534151T3 (en) 8-methyl-1-phenyl-imidazo [1,5-a] pyrazin-COMPOUNDS
RU2800160C2 (ru) Новые производные простого эфира изоксазолила в качестве пам гамк a альфа5
KR20230164602A (ko) 다이아실글리세롤 키나아제 저해제로서 헤테로사이클 화합물 및 이의 용도
AU2011212453B2 (en) 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds